Appointment booking for Dr. Sarah Vodopest, MD is currently not available.Dr. Sarah Vodopest, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Sarah Vodopest, MD (she/her) is a Rheumatologist in Overland Park, KS with over 12 years of experience. What is your opinion of Dr. Sarah Vodopest, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 12 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Sarah Vodopest, MD has received over $2,245 which includes payments from the following companies:
$406.08 from UCB, Inc.
$296.91 from Novartis Pharmaceuticals Corporation
$268.84 from Amgen Inc.
$251.99 from AbbVie, Inc.
$175.06 from Janssen Biotech, Inc.
$108.76 from Relypsa, Inc.
$100.70 from Celgene Corporation
$99.99 from Janssen Scientific Affairs, LLC
$82.13 from LILLY USA, LLC
$73.87 from Mallinckrodt LLC
$73.24 from Regeneron Healthcare Solutions, Inc.
$66.74 from Radius Health, Inc.
$55.51 from E.R. Squibb & Sons, L.L.C.
$54.58 from Horizon Pharma plc
$33.66 from MEDAC PHARMA, INC.
$29.86 from GlaxoSmithKline, LLC.
$15.68 from Antares Pharma, Inc.
$14.09 from Pfizer Inc.
$13.65 from Takeda Pharmaceuticals U.S.A., Inc.
$12.05 from Genentech USA, Inc.
Payments received by Dr. Sarah Vodopest, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!